Scopus
Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination
Kulak Burun Boaz Ihtisas Dergisi KBB Journal of Ear Nose and Throat · Temmuz 2014
Makale Bilgileri
DergiKulak Burun Boaz Ihtisas Dergisi KBB Journal of Ear Nose and Throat
Yayın TarihiTemmuz 2014
Cilt / Sayfa24 · 217-224
Scopus ID2-s2.0-84944148094
Özet
OBJECTIVES: This study aims to compare the effectiveness of desloratadine monotherapy and desloratadine plus montelukast combination therapy on quality of life in patients with persistent allergic rhinitis.PATIENTS AND METHODS: This study consists of 40 patients (28 females, 12 males, mean age 29.8 years; range 17 to 44 years) referred to ear, nose, and throat outpatient clinic between May 2010 and September 2010. A six-week randomized, double-blind, cross-sectional study was performed in two arms: In group 1, 20 patients received desloratadine (5 mg/d) alone; in group 2, 20 patients received desloratadine (5 mg) plus montelukast (10 mg) combination therapy. Quality of life was assessed on the day before starting treatment and on the last day of each treatment period using the Rhinoconjunctivitis Quality of Life Questionnaire and Nighttime Symptom Scores.RESULTS: In group 1, the mean quality of life scores before and after treatment were 3.17 and 2.43, respectively. In group 2, the mean quality of life scores before and after treatment were 2.94 and 1.73, respectively.CONCLUSION: Desloratadine plus montelukast combination therapy may have a positive impact on quality of life, sleep symptoms in particular.
Yazarlar (5)
1
Banu Atalay Erdoğan
2
Arif Sanlı
3
Mustafa Paksoy
4
Gokhan Altin
5
Sedat Aydın
Kurumlar
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Istanbul Turkey
Metrikler
12
Atıf
5
Yazar